Transcript
19 Nov, 2025 | 04:02pm • Source: BSE
Analyst/Investor Call -Call Recording
17 Nov, 2025 | 03:54pm • Source: BSE
Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)
17 Nov, 2025 | 10:36am • Source: NSE
Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)
17 Nov, 2025 | 10:25am • Source: BSE
Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)
17 Nov, 2025 | 10:25am • Source: BSE
Shilpa Medicare Limited has informed the Exchange regarding Board meeting held on November 13, 2025
13 Nov, 2025 | 03:06pm • Source:
Postal Ballot Results published in Newspaper
11 Nov, 2025 | 12:22pm • Source: BSE
Postal Ballot Results published in Newspaper
11 Nov, 2025 | 12:22pm • Source: BSE
Postal Ballot Results
10 Nov, 2025 | 03:17pm • Source: BSE
Shilpa Medicare Limited announces positive phase 3 results of OERIS(TM) -Ondansetron Extended - Release Injection for Chemotherapy - Induced Nausea and Vomiting (CINV).
10 Nov, 2025 | 12:42pm • Source: BSE
Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited, has been awarded the prestigious Gold Medal by EcoVadis, for Excellence in Sustainability
10 Nov, 2025 | 12:21pm • Source: NSE
Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited has been awarded the prestigious Gold Medal by EcoVadis for Excellence in Sustainability.
10 Nov, 2025 | 10:38am • Source: BSE
Schedule of Q2- FY26 Earnings Conference Call
05 Nov, 2025 | 05:44pm • Source: BSE
Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and...
05 Nov, 2025 | 04:42pm • Source: BSE
Shilpa Medicare Limited have signed definitive agreement to sell 31% stake in Sravathi Advance Process Technologies Pvt Ltd.
27 Oct, 2025 | 04:53pm • Source: BSE
The promoters of the Company have entered into an Inter-se Agreement on 16 October 2025
16 Oct, 2025 | 05:00pm • Source: BSE
Shilpa Medicare Limited has informed the Exchange about Certificate Under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018...
10 Oct, 2025 | 02:29pm • Source: NSE
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for Quarter ended 30 September, 2025.
10 Oct, 2025 | 01:24pm • Source: BSE
Postal Ballot Notice published in newspaper
09 Oct, 2025 | 12:31pm • Source: BSE
Postal Ballot Notice
07 Oct, 2025 | 06:19pm • Source: BSE